Navigation Links
St. Gallen consensus 2009: A radically different approach to treating early breast cancer
Date:6/17/2009

A radically different approach to choosing the best treatment options for early breast cancer has been proposed by an international panel of experts in a report from the 11th St Gallen conference.

The report is published online in the cancer journal, Annals of Oncology [1] today (Thursday 18 June), and represents the consensus on early breast cancer treatment that emerged from the conference of more than 4,800 participants from 101 countries, which took place in March 2009.

The authors expect the consensus report to change clinical practice. While it continues to recognise that early breast cancer is a heterogeneous disease and that patients should receive personalised care targeted at their particular type of disease, the report proposes a different way of assessing the disease, its risk and the appropriate treatment.

The authors write: "In distilling patient and tumour features to reach patient treatment decisions, the panel has adopted a fundamentally different approach from that used in previous consensus reports. Clinical decisions in systemic adjuvant therapy of early breast cancer must address three distinct questions: (i) what justifies the use of endocrine therapy, (ii) what justifies the use of anti-HER2 therapy, and (iii) what justifies the use of chemotherapy. Because these decisions are based on quite separate criteria, the previous attempt to produce a single-risk categorization and a separate therapy recommendation are no longer considered appropriate." The authors then give a new algorithm for clinicians to use when deciding on the best treatment approach for each patient.

One of the authors, Professor Richard Gelber (Professor in Biostatistics at Harvard University and Dana-Farber Cancer Institute, Boston, MA, USA and Director of the Statistical Center, International Breast Cancer Study Group), said: "This consensus is important because it provides solutions to open questions in controversial areas con
'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform
2. Experts reach consensus on diagnosis and treatment of bleeding disorders in women
3. Expert consensus on catheter ablation of ventricular arrhythmias
4. SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention
5. Expose on Crimes Against Humanity as Perpetrated by the Gerontological Elite Asks Is Consensus in Anti-Aging Medical Intervention An Elusive Expectation or A Realistic Goal?
6. GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
7. International Panel of Experts Gather for Roundtable Consensus Regarding Multiple Myeloma Related Disease
8. National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future
9. Experts at American Society for Reproductive Medicine (ASRM) Satellite Symposium Reach Consensus: Better Intimacy = Better Overall Well-Being
10. Europe seeks consensus over living wills
11. NQF Endorses Consensus Standards to Reduce Waste and Promote Safe and Effective Use of Imaging Procedures

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ANTACLARA,Calif.,Nov.23/PRNewswire-FirstCall/--New...tictechnologyprovider,announcedtodaythatCEO,Dr.Bra...tthe2ndAnnualLDMICROConferenceonThursday,December3..., Companymanagementwillbeavailableforone-on-onem...3rd.PleasecontactBrettAimeeMaasat(646)536-7331or b...
(Date:11/23/2009)...ANDIEGO,Calif.,Nov.23/PRNewswire-FirstCall/--Orexi...uncedthatfourseniorexecutiveshavejoinedtheorganiza...edevelopmentofitsobesityfranchise.Additionstothema...egulatoryAffairs;SuzanneMcDonald,HeadofManagedMark...GlobalContraveProgram;andWhedyWang,Ph.D,MPH,Headof...
(Date:11/23/2009)... Recognized as Best New Technology...oftware , Radnor, PA (PRW...;s fastest-growing Business Intelligence (BI) soft...ed with the Healthcare IT Innovation™ Award ...ts flagship product, QlikView. The award was prese...
(Date:11/23/2009)... Information about Oxycodone use i... DopeStats.com. The new site is a statistical data...s of Oxycodone in each county in the United States...e used the drug for recreational or medicinal use....) November 23, 2009 -- Legal and illegal Oxycodon...
(Date:11/23/2009)...ORTHANDOVER,Mass.,Nov.23/PRNewswire/--Thistimeofye...nxiety.Oftenthesefeelings,bothpositiveandnegative,...faceit,therearelotsofopportunitiestodosoallseasonl...fmom,sapplepie,buthowmanyofusstopthere?"Thatpieoft...tholidayseasonafterholidayseasontellingourselvesto...
Breaking Medicine News(10 mins):Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Tis' the Season to Eat and Eat More! 2
... from the University of North Carolina have identi... or migration. // The protein, CIB1, or calci...discovered at UNC in 1997 as a blood platelet prot...pment, new blood vessel formation and wound healin...
...-old boy in a West Bengal town is said to be in sl...his Rip Van Winkle act. // Reports Saturday s...ict was an active and playful boy of eight until 1...d for feeding and answering nature's call. ...
...ry active leisure time can reduce the chances of h...chemic stroke. Researchers from National Public He...these findings in the journal Stroke: Journal of t...of them healthy and without any previous history o...
...als have devised a new system that ranks foods acc...as designed and developed// by a panel of independ... from the food industry and consumer groups, as we...has evolved through consultations over the last fe...
... from Douglas Hospital Research Center in Montreal...are more equipped to deal with stressful situation...though the benefits of breast-feeding are well est...ood for the mothers as such mothers will be able t...
...mains one of the significant health problems to be.... It requires a multi faceted approach. A protein-...ype II diabetes. A recent study shows that co...ividuals control their blood sugar levels after a ...
Other Medicine News:Health News:Identified Protein To Inhibit Cell Migration 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Nutrient Profiling System Launched By Food Officials in UK 2Health News:Breastfeeding Lowers Maternal Stress 2Health News:Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture 2
(Date:11/20/2009)..., , WAYNE, Pa., Nov. 20 /PRNewswire-FirstCa... announced the results for its fiscal first quarte...quarter of fiscal 2010, product revenue decreased ...ing the three-month period ended September 30, 200... The Company reported the decreased net revenue o...
(Date:11/20/2009)..., , LARGO, Fla., Nov. 20 /PRNewswire-FirstC...VICF; TSX Venture Exchange: UVI), which develops, ...ecialty contact lenses, today reported its operati...0, 2009 (FY2010). ,, Net sales excluding royalt...ter, 4.4% less then $1,761,526 reported in the pre...
(Date:11/20/2009)..., , LOUISVILLE, Ky., Nov. 20 /PRNewswire...vestigators (NADDI) today announced a new initiati...ecursor Log Exchange (NPLEx) is a multi-state elec...itations on over-the-counter (OTC) medicines conta... sale. The technology for NPLEx is based on a sys...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 1Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 2Sanofi Pasteur Submits Supplemental Application for A 28H1N1 29 Pandemic Vaccine to U S FDA 4835 3
...scientific evidence supporting accuracy of, its ...or international conf... 7 Molecular,Biometrics, LLC, a privately-held me... for applications in personalized medicine to more...th and disease, presented data from,four new studi...
...ure Corporation,(Nasdaq: BPUR ) announced today t...Administration (FDA) on identifying an acceptable ...opure(R) [hemoglobin glutamer -,250 (bovine)], or ...opure,in patients suffering from Acute Myelogenous...components. Currently, AML patients who do not,acc...
Other Medicine Technology:Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3
Prechopper angled for soft cataracts
Prechopper angled
Dodick Nucleus Cracker
Dodick Irrigating Nucleus Chopper
Medicine Products: